Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $45.51 | 3.76% | 15.24% | 15.42% | 36.42% | 81.10% | 233.16% | 502.78% | 286.99% | 226.00% | $45.83 | $15.16 | 0.70% | 200.20% | 1.87 | 3,266,102 | 21.23% |
| AUPH | AURINIA PHARMACEUTICALS INC | $8.24 | 1.48% | 1.85% | 2.49% | 3.00% | 11.96% | 61.89% | -24.33% | -52.20% | 115.71% | $10.67 | $4.99 | 22.77% | 65.13% | 1.06 | 1,071,675 | 18.10% |
| CORT | CORCEPT THERAPEUTICS INC | $71.88 | -1.84% | 3.77% | -37.07% | 2.83% | 53.29% | 208.23% | 225.99% | 467.77% | 1,145.75% | $117.33 | $23.02 | 38.74% | 212.25% | 0.92 | 809,594 | -0.91% |
| KRYS | KRYSTAL BIOTECH INC | $169.88 | -0.40% | 2.46% | -5.78% | 8.85% | -3.22% | 10.95% | 166.90% | 259.99% | N/A | $219.34 | $141.72 | 22.55% | 19.87% | 1.34 | 210,944 | -18.09% |
| NAGE | NIAGEN BIOSCIENCE INC | $7.85 | 0.90% | 9.18% | 13.77% | 33.50% | 119.27% | 121.75% | 294.47% | 57.00% | 119.89% | $9.18 | $2.31 | 14.49% | 240.56% | 1.23 | 411,930 | 11.05% |
| SPRY | ARS PHARMACEUTICALS INC | $13.97 | 0.36% | -2.85% | 11.05% | -2.24% | -2.10% | 60.57% | 343.49% | N/A | N/A | $18.51 | $7.55 | 24.53% | 85.03% | 1.02 | 1,025,554 | 54.15% |
| GYRE | GYRE THERAPEUTICS INC | $9.76 | 1.99% | 6.20% | 26.42% | -15.13% | -33.65% | -37.44% | 37.81% | -89.26% | -99.73% | $19.00 | $6.11 | 48.63% | 59.74% | 1.13 | 84,234 | 49.06% |
| ARGX | ARGENX SE | $645.14 | 2.48% | 8.49% | 9.00% | -3.09% | 16.93% | 71.81% | 119.92% | 340.40% | N/A | $678.21 | $352.77 | 4.88% | 82.88% | 0.70 | 319,772 | 38.37% |
| CPRX | CATALYST PHARMACEUTICALS INC | $24.29 | 0.04% | 5.06% | 0.16% | 4.74% | 12.66% | 61.40% | 211.01% | 412.45% | 668.67% | $26.16 | $14.47 | 7.14% | 67.86% | 1.07 | 941,751 | 31.23% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.47 | 0.10% | 1.97% | -11.21% | -25.47% | -12.81% | -4.66% | -34.66% | N/A | N/A | $41.61 | $26.47 | 29.18% | 11.33% | 0.85 | 435,201 | 4.86% |
| VCEL | VERICEL CORP | $38.02 | -3.40% | -5.07% | -14.79% | -35.83% | -16.51% | -17.11% | 26.90% | 162.21% | 1,048.64% | $63.00 | $37.76 | 39.65% | 0.69% | 1.43 | 384,627 | -2.00% |
| EXEL | EXELIXIS INC | $39.15 | 1.56% | 6.44% | 6.04% | 18.89% | 20.68% | 66.88% | 72.77% | 58.53% | 1,423.35% | $40.02 | $20.14 | 2.17% | 94.39% | 0.62 | 2,150,698 | 20.40% |
| SRPT | SAREPTA THERAPEUTICS INC | $62.40 | 2.55% | 4.89% | -2.23% | -45.48% | -51.17% | -50.73% | -15.42% | -47.06% | 411.48% | $173.25 | $48.01 | 63.98% | 29.97% | 0.91 | 1,576,612 | -21.01% |
| HALO | HALOZYME THERAPEUTICS INC | $61.42 | 0.99% | 5.15% | -3.75% | 8.86% | 21.41% | 61.21% | 50.35% | 171.11% | 313.05% | $66.00 | $38.88 | 6.94% | 57.97% | 0.85 | 1,366,117 | 19.00% |
| RIGL | RIGEL PHARMACEUTICALS INC | $19.56 | -0.05% | 7.71% | 8.73% | -13.45% | 37.07% | 86.29% | -20.49% | 9.27% | -54.08% | $29.82 | $7.48 | 34.41% | 161.36% | 1.38 | 146,975 | -24.48% |
| RPRX | ROYALTY PHARMA PLC | $32.82 | 0.34% | 3.57% | 5.43% | 3.89% | 20.71% | 18.48% | -22.50% | N/A | N/A | $34.20 | $24.05 | 4.04% | 36.47% | 0.53 | 4,545,721 | 73.97% |
| NVO | NOVO NORDISK A S | $66.45 | 1.98% | 8.40% | -4.31% | -22.13% | -41.32% | -48.21% | 16.74% | 109.85% | 136.18% | $148.15 | $57.00 | 55.15% | 16.58% | 0.57 | 9,214,791 | -15.64% |
| MDXG | MIMEDX GROUP INC | $6.88 | -0.58% | 1.78% | -9.47% | -22.78% | 20.91% | 11.69% | 74.18% | N/A | -26.81% | $10.14 | $5.47 | 32.15% | 25.78% | 1.22 | 703,474 | 18.73% |
| ADMA | ADMA BIOLOGICS INC | $23.80 | -1.29% | 9.53% | 19.96% | 47.83% | 40.33% | 265.03% | 1,159.26% | 706.78% | 183.00% | $25.67 | $6.60 | 7.28% | 260.61% | 1.06 | 2,807,404 | -45.03% |
| INCY | INCYTE CORP | $62.66 | 3.69% | 8.03% | 3.48% | -15.06% | -15.24% | 20.38% | -17.61% | -35.84% | -35.51% | $83.95 | $52.28 | 25.36% | 19.85% | 0.58 | 2,822,211 | -3.74% |
| MNKD | MANNKIND CORP | $5.04 | 2.65% | 9.33% | 0.20% | -15.58% | -28.21% | 22.63% | 53.66% | 287.69% | -76.50% | $7.63 | $4.17 | 33.94% | 21.01% | 1.10 | 2,007,597 | 6.22% |
| VCYT | VERACYTE INC | $30.50 | -2.80% | -3.07% | 2.87% | -33.90% | -12.86% | 55.85% | 41.27% | 13.09% | 233.33% | $47.32 | $19.71 | 35.54% | 54.74% | 1.92 | 1,071,053 | 28.38% |
| GNFT | GENFIT SA | $4.10 | 1.11% | 12.44% | 19.74% | 3.15% | -30.00% | 17.00% | 13.75% | -80.73% | N/A | $6.42 | $2.55 | 36.24% | 60.59% | 0.36 | 2,961 | -86.57% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $116.96 | 0.47% | 12.26% | -5.79% | -6.47% | 3.34% | 5.61% | -25.65% | 6.09% | -34.55% | $148.06 | $95.49 | 21.00% | 22.48% | 0.71 | 1,127,014 | 5.56% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $63.69 | 0.65% | 2.83% | -9.90% | -0.30% | -4.48% | -21.14% | -23.55% | -30.79% | -43.16% | $94.85 | $52.93 | 32.85% | 20.33% | 0.74 | 1,296,496 | 5.74% |
| TECH | BIO-TECHNE CORP | $50.35 | -0.30% | 0.38% | -14.12% | -30.80% | -33.77% | -20.34% | -47.36% | -10.49% | 109.88% | $85.57 | $46.01 | 41.16% | 9.43% | 1.13 | 1,529,977 | 14.57% |
| ACAD | ACADIA PHARMACEUTICALS INC | $14.60 | 1.18% | -0.14% | -12.10% | -21.88% | -1.15% | -12.63% | -25.28% | -69.78% | -57.27% | $20.68 | $13.40 | 29.40% | 8.96% | 0.88 | 1,863,243 | 17.40% |
| GMAB | GENMAB A | $21.15 | 1.73% | 5.07% | 8.02% | 6.76% | -6.29% | -23.62% | -39.24% | -13.07% | 174.11% | $30.41 | $17.24 | 30.45% | 22.72% | 0.72 | 1,354,443 | 10.03% |
| UTHR | UNITED THERAPEUTICS CORP | $303.09 | 0.77% | 3.28% | -1.68% | -13.97% | -16.13% | 29.34% | 68.55% | 176.64% | 89.80% | $417.82 | $253.93 | 27.46% | 19.36% | 0.49 | 784,301 | 36.43% |
| REGN | REGENERON PHARMACEUTICALS INC | $598.76 | 5.25% | 1.86% | -5.59% | -12.34% | -35.11% | -32.77% | -8.17% | 13.86% | 30.89% | $1.21k | $525.99 | 50.56% | 13.83% | 0.59 | 1,616,921 | -39.22% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.